Literature DB >> 23291169

AMP-activated protein kinase phosphorylates CtBP1 and down-regulates its activity.

Jae-Hwan Kim1, Soo-Youn Choi, Byung-Hee Kang, Soon-Min Lee, Hyung Soon Park, Gum-Yong Kang, Joo Young Bang, Eun-Jung Cho, Hong-Duk Youn.   

Abstract

CtBP is a transcriptional repressor which plays a significant role in the regulation of cell proliferation and tumor progression. It was reported that glucose withdrawal causes induction of Bax due to the dissociation of CtBP from the Bax promoter. However, the precise mechanism involved in the regulation of CtBP still remains unclear. In this study, we found that an activated AMP-activated protein kinase (AMPK) phosphorylates CtBP1 on Ser-158 upon metabolic stresses. Moreover, AMPK-mediated phosphorylation of CtBP1 (S158) attenuates the repressive function of CtBP1. We also confirmed that triggering activation of AMPK by various factors resulted in an increase of Bax gene expression. These findings provide connections of AMPK with CtBP1-mediated regulation of Bax expression for cell death under metabolic stresses.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23291169     DOI: 10.1016/j.bbrc.2012.12.117

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Components of the CtBP1/BARS-dependent fission machinery.

Authors:  Carmen Valente; Alberto Luini; Daniela Corda
Journal:  Histochem Cell Biol       Date:  2013-09-01       Impact factor: 4.304

2.  Adiponectin enhances bone marrow mesenchymal stem cell resistance to flow shear stress through AMP-activated protein kinase signaling.

Authors:  Lin Zhao; Chongxi Fan; Yu Zhang; Yang Yang; Dongjin Wang; Chao Deng; Wei Hu; Zhiqiang Ma; Shuai Jiang; Shouyi Di; Zhigang Qin; Jianjun Lv; Yang Sun; Wei Yi
Journal:  Sci Rep       Date:  2016-07-15       Impact factor: 4.379

Review 3.  CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors.

Authors:  M Michael Dcona; Benjamin L Morris; Keith C Ellis; Steven R Grossman
Journal:  Cancer Biol Ther       Date:  2017-05-22       Impact factor: 4.742

4.  Identification of Type 2 Diabetes Biomarkers From Mixed Single-Cell Sequencing Data With Feature Selection Methods.

Authors:  Zhandong Li; Xiaoyong Pan; Yu-Dong Cai
Journal:  Front Bioeng Biotechnol       Date:  2022-06-02

5.  C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer.

Authors:  Jung S Byun; Kevin Gardner
Journal:  Int J Cell Biol       Date:  2013-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.